The multinational Bayer owns Monsanto and the herbicide Roundup.
For Ron Miller, Bayer made bad choices in this matter. The fact that they did not seek more to reach an amicable agreement is a mystery.
The group has reaffirmed its intention to go to trial each time it is attacked over the alleged effects of Roundup.
It emphasized that it has won its case in several recent proceedings related to Roundup, based on evaluations by regulators and scientists who continue to consider this product safe.
In mid-November, a Missouri court jury awarded Monsanto $1.5 billion in damages to three Americans who also blamed their non-Hodgkin's lymphoma for to years of use of Roundup.
The group also appealed this conviction.
According to Bayer, 113,000 of the approximately 165,000 lawsuits filed against Monsanto related to the herbicide have been resolved or declared inadmissible to date.
In June 2020, the pharmaceutical and biotechnology giant reached an out-of-court settlement covering, according to the company, approximately 75% of the 125,000 shares then outstanding.
The transaction provided for a total payment of between 10.1 and 10.9 billion US dollars.
Bayer also spent 400 million dollars to compensate people exposed to another herbicide, dicamba, and 820 million for disputes linked to PCBs (polychlorinated biphenyls), so-called eternal pollutants.
In 2021, the company allocated an additional US$4.5 billion to manage these procedures, bringing the total envelope to more than 16 billion.